Philippe Beuzeboc
ScholarGPS® ID: 68320112531073
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Breast Cancer | Prostate Cancer | Chemotherapy | Docetaxel | Neoplasm | Metastatic Breast Cancer | Hormone | Trastuzumab | Doxorubicin | Chronic Kidney Disease | Radiation Therapy | Cisplatin | Fluorouracil | Androgen Suppression
Metrics Summary
Publication Count
372
Predicted Citations
12,621
Predicted h-index
60
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer (journal article) Future Oncology (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 4509-4509 (2024). |
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer (journal article) International Journal of Molecular Sciences, volume 25, issue 11, pages 6058- (2024). |
BMJ Supportive & Palliative Care, volume 14, issue e1, pages e919-e927 (2024). |
Annals of Oncology, volume 35, issue 4, pages 392-401 (2024). |
Vaccination against HPV: Easier said than done? (journal article) Human Vaccines & Immunotherapeutics, volume 19, issue 3 (2023). |
“Emergency” multidisciplinary team meeting in cancer: a first feedback from a care team (journal article) Journal of Translational Medicine, volume 21, issue 1 (2023). |
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer (journal article) Prostate Cancer and Prostatic Diseases (2023). |
Bio‐ethical issues in oncology during the first wave of the COVID‐19 epidemic: A qualitative study in a French hospital (journal article) Journal of Evaluation in Clinical Practice, volume 29, issue 6, pages 925-933 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 4514-4514 (2023). |
Nouvelles AMM : olaparib en combinaison à l’abiratérone dans le cancer de la prostate métastatique résistant à la castration (journal article) Bulletin du Cancer, volume 110, issue 4, pages 339-341 (2023). |
Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 526-526 (2023). |
Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 126-126 (2023). |
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer (journal article) Pharmaceutics, volume 15, issue 2, pages 651- (2023). |
Cancer and COVID-19: ethical issues concerning the use of telemedicine during the pandemic (journal article) BMC Health Services Research, volume 22, issue 1 (2022). |
An ethics of HPV vaccination: beyond principlism (journal article) Human Vaccines & Immunotherapeutics, volume 18, issue 5 (2022). |
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics (journal article) BMC Medical Ethics, volume 23, issue 1 (2022). |
Vaccine refusal and burnout: Hospitals need “emergency multidisciplinary team meetings” (journal article) Journal of Evaluation in Clinical Practice, volume 28, issue 3, pages 493-494 (2022). |
Médecine de Catastrophe - Urgences Collectives, volume 6, issue 2, pages 99-104 (2022). |
MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPY (journal article) Journal of Urology, volume 207, issue Supplement 5 (2022). |